| Ticker Details |
|
Vaxart, Inc
|
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 4.96%
|
| Avg Daily Range (30 D): |
$0.03 | 3.85%
|
| Avg Daily Range (90 D): |
$0.03 | 4.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.49M |
| Avg Daily Volume (30 D): |
.45M |
| Avg Daily Volume (90 D): |
.57M |
| Trade Size |
| Avg Trade Size (Sh.): |
297 |
| Avg Trade Size (Sh.) (30 D): |
1,143 |
| Avg Trade Size (Sh.) (90 D): |
1,114 |
| Institutional Trades |
| Total Institutional Trades: |
1,120 |
| Avg Institutional Trade: |
$1.61M |
| Avg Institutional Trade (30 D): |
$.66M |
| Avg Institutional Trade (90 D): |
$.66M |
| Avg Institutional Trade Volume: |
.28M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.86M |
| Avg Closing Trade (30 D): |
$1.31M |
| Avg Closing Trade (90 D): |
$1.31M |
| Avg Closing Volume: |
388.98K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$.24
|
|
$-.07
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$104.24M
|
|
$20.88M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$55.05M
|
|
$-15.59M
|
|
Operating Income / Loss
|
$55.42M
|
|
$-14.94M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$36.93M
|
|
$3.47M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Feb 14, 2018
|
1:11
|
|
Nov 09, 2012
|
1:6
|
|
|
|